Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 1× · first seen 13-nov-2026 · last seen 13-nov-2026

Elamipretide (SS-31)

Current understanding

To be populated as evidence accumulates.

Evidence log

  • 2026-11-11 — The Short Peptide Elamipretide Delays Ovarian Aging in Mice: [animal-model] A news report describes improved oocyte quality and delayed ovarian aging in elamipretide-treated mice, alongside improved quality in human oocytes treated in vitro; these preclinical findings do not establish fertility benefits or delayed ovarian aging in women. [animal-model] (novelty: 3)

Open questions

Related

Contributing findings

rss news report animal-model
The Short Peptide Elamipretide Delays Ovarian Aging in Mice
11-nov-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18